Loading...

Margin Erosion And Geopolitical Risks Will Hinder Clinical Trials

Published
16 Apr 25
Updated
07 May 25
n/a
n/a
AnalystLowTarget's Fair Value
n/a
Loading
1Y
-15.6%
7D
3.0%

Author's Valuation

US$163.859.7% overvalued intrinsic discount

AnalystLowTarget Fair Value